000			02187 a2200565 4500
005			20250515173131.0
264		0	_c20090820
008			200908s 0 0 eng d
022			_a1527-7755
024	7		_a10.1200/JCO.2008.18.6999 _2doi
040			_aNLM _beng _cNLM
100	1		_aKantarjian, Hagop M
245	0	0	_aSignificance of increasing levels of minimal residual disease in patients with Philadelphia chromosome-positive chronic myelogenous leukemia in complete cytogenetic response. _h[electronic resource]
260			_bJournal of clinical oncology : official journal of the American Society of Clinical Oncology _cAug 2009
300			_a3659-63 p. _bdigital
500			_aPublication Type: Comparative Study; Journal Article; Research Support, N.I.H., Extramural
650	0	4	_aBenzamides
650	0	4	_aCause of Death
650	0	4	_aCohort Studies
650	0	4	_aCytogenetics
650	0	4	_aDisease-Free Survival
650	0	4	_aDose-Response Relationship, Drug
650	0	4	_aFemale
650	0	4	_aFollow-Up Studies
650	0	4	_aFusion Proteins, bcr-abl _xgenetics
650	0	4	_aHumans
650	0	4	_aImatinib Mesylate
650	0	4	_aIncidence
650	0	4	_aLeukemia, Myelogenous, Chronic, BCR-ABL Positive _xdrug therapy
650	0	4	_aNeoplasm, Residual _xdrug therapy
650	0	4	_aPhiladelphia Chromosome
650	0	4	_aPiperazines _xadministration & dosage
650	0	4	_aPolymerase Chain Reaction
650	0	4	_aProbability
650	0	4	_aProtein Kinase Inhibitors _xadministration & dosage
650	0	4	_aPyrimidines _xadministration & dosage
650	0	4	_aSensitivity and Specificity
650	0	4	_aSeverity of Illness Index
650	0	4	_aSurvival Analysis
650	0	4	_aTime Factors
650	0	4	_aTreatment Outcome
700	1		_aShan, Jianqin
700	1		_aJones, Daniel
700	1		_aO'Brien, Susan
700	1		_aRios, Mary Beth
700	1		_aJabbour, Elias
700	1		_aCortes, Jorge
773	0		_tJournal of clinical oncology : official journal of the American Society of Clinical Oncology _gvol. 27 _gno. 22 _gp. 3659-63
856	4	0	_uhttps://doi.org/10.1200/JCO.2008.18.6999 _zAvailable from publisher's website
999			_c18912184 _d18912184